(2). The structure of all compounds is fully supported by spectroscopic and analytical techniques and by X-ray diffraction studies for compounds 2, 3, and 5. All cationic compounds are cytotoxic in the two breast cancer cell lines tested, MCF7 and MDA-MB-231, and much better than cisplatin under the same experimental conditions. The cytotoxicity of the biotinylated compounds seems to be related with
预期的抗癌
金属药物应在设计中考虑目标特异性成分,以克服当前
化学疗法的局限性。
维生素在许多癌
细胞系中都过表达,这种
维生素被证明是一种有效的策略。因此,在本文中,我们报告了一组新化合物[Ru(η5-
C5H5)(P(C6H4R)3)(4,4'-R'-2,2'-bpy)] +( R = F和R'= H,3; R = F和R'=
生物素,4; R = OCH3和R'= H,5; R = OCH3和R'=
生物素,6)最近获得了带有三苯基
膦配体的类似物的结果。还根据修改的文献程序[Ru(η5- )(P(C6H4R)3)2Cl]描述了这些合成的前体,其中R为-F(1)或-OCH3(2)。光谱,分析技术以及化合物2、3和5的X射线衍射研究充分支持了所有化合物的结构。在所测试的两种乳腺癌细胞MCF7和
MDA-MB-231中,所有阳离子化合物均具有细胞毒性。在相同的实验条件下,其效果要比
顺铂好得多。
生物素化